Cancer cells treated with BRD4 inhibitors subsequently suffer not only damage arising from double-strand breaks and R-loop accrual at a subset of BRD4-controlled genes but also mitotic catastrophe, all leading to cell death [90,91]. This evidence concerns the gene BRD4 and cancer.